Integrated Bioinformatics analysis and clinical validation reveals that high expression of mucin 1 in intrahepatic cholangiocarcinoma predicts recurrence after curative resection
Feiyu Chen(Sun Yat-sen University), Zheng Wang(McMaster University), Cheng Zhou(Fudan University), Jie Hu(Zhongshan Hospital), Jian Zhou(Shenzhen University Health Science Center), Lei Yu(Taiyuan Central Hospital), Jia Fan(Nanjing Tech University), Kaiqian Zhou(Ministry of Education), Xiangyu Zhang(North China Electric Power University), Yuan‐Fei Peng(Fudan University)
Cited by 7
Related Papers
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
|Liver Cancer|2020|828
Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
|Journal of Clinical Oncology|2011|644